Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 11 (2013): Issue 2 (Feb 2013)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
NCCN News
Pages: xxvi–xxvii
Oncology Research Program
Pages: xxviii
NCCN's Value Pathways: The Drive for Quality Cancer Care
By:
Patricia J. Goldsmith
Pages: 119–120
Defining Cancer Care Quality or Delivering Quality Cancer Care?
By:
Matt Brow
,
J. Russell Hoverman
,
Debra Patt
,
Bill Herman
,
Diana Verrilli
,
Jody Garey
and
Roy Beveridge
Pages: 121–124
Ten Years of Progress Against Breast Cancer: A Partnership of Basic and Clinical/Translational Science
By:
Robert W. Carlson
and
on behalf of the NCCN Breast Cancer Panel
Pages: 132–136
Brentuximab in the Treatment of CD30-Positive Enteropathy-Associated T-Cell Lymphoma
By:
Waleed F. Khalaf
,
Meghan E. Caldwell
and
Nishitha Reddy
Pages: 137–140
Metastatic Colon Cancer, Version 3.2013
Featured Updates to the NCCN Guidelines
By:
Al B. Benson III
,
Tanios Bekaii-Saab
,
Emily Chan
,
Yi-Jen Chen
,
Michael A. Choti
,
Harry S. Cooper
,
Paul F. Engstrom
,
Peter C. Enzinger
,
Marwan G. Fakih
,
Moon J. Fenton
,
Charles S. Fuchs
,
Jean L. Grem
,
Steven Hunt
,
Ahmed Kamel
,
Lucille A. Leong
,
Edward Lin
,
Kilian Salerno May
,
Mary F. Mulcahy
,
Kate Murphy
,
Eric Rohren
,
David P. Ryan
,
Leonard Saltz
,
Sunil Sharma
,
David Shibata
,
John M. Skibber
,
William Small Jr
,
Constantinos T. Sofocleous
,
Alan P. Venook
,
Christopher G. Willett
,
Kristina M. Gregory
and
Deborah A. Freedman-Cass
Pages: 141–152
Local Therapies for Hepatic Metastases
By:
Fabian M. Johnston
,
Michael N. Mavros
,
Joseph M. Herman
and
Timothy M. Pawlik
Pages: 153–160
Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancers
By:
Helena A. Yu
and
Gregory J. Riely
Pages: 161–169
Using Multigene Tests to Select Treatment for Early-Stage Breast Cancer
By:
Rodrigo Goncalves
and
Ron Bose
Pages: 174–182
The Role of Active Surveillance in the Management of Prostate Cancer
By:
Simon D. Fung-Kee-Fung
,
Sima P. Porten
,
Maxwell V. Meng
and
Michael Kuettel
Pages: 183–187
Distress Management
By:
Jimmie C. Holland
,
Barbara Andersen
,
William S. Breitbart
,
Luke O. Buchmann
,
Bruce Compas
,
Teresa L. Deshields
,
Moreen M. Dudley
,
Stewart Fleishman
,
Caryl D. Fulcher
,
Donna B. Greenberg
,
Carl B. Greiner
,
George F. Handzo
,
Laura Hoofring
,
Charles Hoover
,
Paul B. Jacobsen
,
Elizabeth Kvale
,
Michael H. Levy
,
Matthew J. Loscalzo
,
Randi McAllister-Black
,
Karen Y. Mechanic
,
Oxana Palesh
,
Janice P. Pazar
,
Michelle B. Riba
,
Kristin Roper
,
Alan D. Valentine
,
Lynne I. Wagner
,
Michael A. Zevon
,
Nicole R. McMillian
and
Deborah A. Freedman-Cass
Pages: 190–209
Using the Science of Psychosocial Care to Implement the New American College of Surgeons Commission on Cancer Distress Screening Standard
By:
Lynne I. Wagner
,
David Spiegel
and
Timothy Pearman
Pages: 214–221
Progress in the Implementation of NCCN Guidelines for Distress Management by Member Institutions
By:
Kristine A. Donovan
and
Paul B. Jacobsen
Pages: 223–226
An Update on NCCN/NBGH Initiative to Develop Evidence-Based Cancer Treatment Recommendations: Year 3
By:
Elizabeth Danielson
Pages: 227–228
Collapse
Expand
Search
Issue
Journal
[3.239.40.250]
3.239.40.250
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
